III. Cost-effectiveness of Medical Oncology
نویسندگان
چکیده
منابع مشابه
Cost-effectiveness analysis in oncology.
Economic evaluations in cancer have become increasingly important because of the rising incidence of the disease and the proliferation of effective therapies. The aging of the population and the increasing costs of care make it even more important to identify those treatments of greatest value from both an effectiveness and cost perspective. Economic research can be conducted at the "macro" lev...
متن کاملCost-effectiveness of PET imaging in clinical oncology.
To be cost-effective, PET must be diagnostically accurate and effective in improving management without increasing treatment cost. To evaluate diagnostic accuracy, we performed prospective evaluations of whole-body PET imaging in staging of non-small-cell lung cancer (99 patients), detection of recurrent colorectal cancer (57 patients), diagnosis of metastatic melanoma (36 patients), and stagin...
متن کاملCost-effectiveness analysis of medical documentation alternatives.
OBJECTIVES The delay between patient discharge and the completion of the final discharge note have prompted hospitals to consider new information technologies. This study compared the relative cost-effectiveness of an automated medical documentation system to the current system in place at a Canadian hospital. There are significant expenditures associated with the choice of medical documentatio...
متن کاملMedical Oncology
Objective: Present how the SSG register of bone and soft tissue sarcoma patients has an important role for ensuring quality control and as a basis for research projects. Methods: The SSG Register was initiated in 1986 and more than 5000 patients from sarcoma centers in Finland, Norway and Sweden have been accrued. Patient data was registered at the participating institutions. For in-depth studi...
متن کاملCost, effectiveness, and cost-effectiveness.
Incremental or marginal cost-effectiveness ratios are founded on a number of assumptions that weaken their suitability as a way to balance competing economic and clinical priorities. We therefore propose a more relevant and responsible way to gauge the impact of clinical management strategies based on “consumer protection” principles—explicit disclosure of (1) the total magnitude of expected be...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Nihon Naika Gakkai Zasshi
سال: 2017
ISSN: 0021-5384,1883-2083
DOI: 10.2169/naika.106.1125